Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C26H36N2O5.ClH |
| Molecular Weight | 493.035 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC=C(CCN(C)CCCN2CCC3=C(CC2=O)C=C(OC)C(OC)=C3)C=C1OC
InChI
InChIKey=ZRNKXJHEQKMWCH-UHFFFAOYSA-N
InChI=1S/C26H36N2O5.ClH/c1-27(13-9-19-7-8-22(30-2)23(15-19)31-3)11-6-12-28-14-10-20-16-24(32-4)25(33-5)17-21(20)18-26(28)29;/h7-8,15-17H,6,9-14,18H2,1-5H3;1H
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C26H36N2O5 |
| Molecular Weight | 456.5744 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionCurator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/15648302 | https://www.ncbi.nlm.nih.gov/pubmed/14561092 |
https://www.ncbi.nlm.nih.gov/pubmed/19093365
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/15648302 | https://www.ncbi.nlm.nih.gov/pubmed/14561092 |
https://www.ncbi.nlm.nih.gov/pubmed/19093365
Zatebradine is a bradycardic compound that blocks hyperpolarization-activated inward current (If) through cyclic nucleotide-gated cation (HCN) channels in sinoatrial node cells. Additionally, it can block voltage-gated outward K+ (IK) currents and related neuronal hyperpolarization-activated inward current (Ih) channels but exhibits little or no activity for L-type Ca2+ (ICa) currents. When assessed through telemetric ECG recording in mice, zatebradine reduced heart rate from 600 to 200 beats per minute with an ED50 value of 1.8 mg/kg and induced increasing arrhythmia at concentrations >10 mg/kg.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of zatebradine on contractility, relaxation and coronary blood flow. | 1993 Feb |
|
| Zatebradine, a specific bradycardic agent, enhances the positive inotropic actions of dobutamine in ischemic myocardium. | 1994 Jan |
|
| Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group. | 1995 Aug |
|
| Effects of zatebradine on ouabain-, two-stage coronary ligation- and epinephrine-induced ventricular tachyarrhythmias. | 1996 Apr 11 |
|
| Increases in inotropic state without change in heart rate: combined use of dobutamine and zatebradine in conscious dogs. | 1996 Dec 5 |
Sample Use Guides
Rats were treated with Zatebradine at dose 3 mg/kg i.v
Route of Administration:
Intravenous
Sinoatrial node pacemaker cells were isolated enzymatically from rabbit hearts. The inward currents, elicited by hyperpolarizing pulses of 2000 ms from a holding potential of −40 mV to −140 mV in 10 mV increments and then clamp back to 0 mV for 1000 ms, were recorded first in the absence and then in the presence of zatebradine or CsCl. The established If blockers zatebradine (1 mkM) and CsCl (2 mM) inhibited If by 63.7 ± 8.4% and 91.8 ± 5.6%, respectively
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:41:42 GMT 2023
by
admin
on
Fri Dec 15 15:41:42 GMT 2023
|
| Record UNII |
WJB7DYV16A
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3045335
Created by
admin on Fri Dec 15 15:41:42 GMT 2023 , Edited by admin on Fri Dec 15 15:41:42 GMT 2023
|
PRIMARY | |||
|
WJB7DYV16A
Created by
admin on Fri Dec 15 15:41:42 GMT 2023 , Edited by admin on Fri Dec 15 15:41:42 GMT 2023
|
PRIMARY | |||
|
DTXSID6045745
Created by
admin on Fri Dec 15 15:41:42 GMT 2023 , Edited by admin on Fri Dec 15 15:41:42 GMT 2023
|
PRIMARY | |||
|
m11583
Created by
admin on Fri Dec 15 15:41:42 GMT 2023 , Edited by admin on Fri Dec 15 15:41:42 GMT 2023
|
PRIMARY | Merck Index | ||
|
91940-87-3
Created by
admin on Fri Dec 15 15:41:42 GMT 2023 , Edited by admin on Fri Dec 15 15:41:42 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |